Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity

被引:32
作者
Gunasekera, Sunithi [1 ]
Muhammad, Taj [1 ]
Stromstedt, Adam A. [1 ]
Rosengren, K. Johan [2 ]
Goransson, Ulf [1 ]
机构
[1] Uppsala Univ, Dept Med Chem, Biomed Ctr, Pharmacognosy, Box 574, S-75123 Uppsala, Sweden
[2] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia
基金
瑞典研究理事会;
关键词
antibiotics; cytotoxicity; drug discovery; peptides; structure-activity relationships; HUMAN CATHELICIDIN LL-37; CANDIDA-ALBICANS; DETERMINES; ANTIFUNGAL; CONFORMATION; SELECTIVITY; MICELLES; CELLS;
D O I
10.1002/cbic.201700599
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human host defence peptide LL-37 is a broad-spectrum antibiotic with immunomodulatory functions. Residues 18-29 in LL-37 have previously been identified as a minimal peptide (KR-12) that retains antibacterial activity with decreased cytotoxicity. In this study, analogues of KR-12 were generated by Ala and Lys scans to identify key elements for activity. These were tested against a panel of human pathogens and for membrane permeabilisation on liposomes. Replacements of hydrophobic and cationic residues with Ala were detrimental for antibiotic potency. Substitutions by Lys increased activity, as long as the increase in cationic density did not disrupt the amphiphilic disposition of the helical structure. Importantly, substitutions showed differential effects against different organisms. Replacement of Gln5 with Lys and Asp9 with Ala or Lys improved the broad-spectrum activity most, each resulting in up to an eightfold increase in potency against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. The improved analogues displayed no significant toxicity against human cells, and thus, KR-12 is a tuneable template for antibiotic development.
引用
收藏
页码:931 / 939
页数:9
相关论文
共 38 条
[1]   The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].
Agerberth, B ;
Charo, J ;
Werr, J ;
Olsson, B ;
Idali, F ;
Lindbom, L ;
Kiessling, R ;
Jörnvall, H ;
Wigzell, H ;
Gudmundsson, GH .
BLOOD, 2000, 96 (09) :3086-3093
[2]   Real-time attack of LL-37 on single Bacillus subtilis cells [J].
Barns, Kenneth J. ;
Weisshaar, James C. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2013, 1828 (06) :1511-1520
[3]   Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses [J].
Brown, Kelly L. ;
Poon, Grace F. T. ;
Birkenhead, Darlene ;
Pena, Olga M. ;
Falsafi, Reza ;
Dahlgren, Claes ;
Karlsson, Anna ;
Bylund, Johan ;
Hancock, Robert E. W. ;
Johnson, Pauline .
JOURNAL OF IMMUNOLOGY, 2011, 186 (09) :5497-5505
[4]   The chemistry and biology of LL-37 [J].
Burton, Matthew F. ;
Steel, Patrick G. .
NATURAL PRODUCT REPORTS, 2009, 26 (12) :1572-1584
[5]   LL-37, the only human member of the cathelicidin family of antimicrobial peptides [J].
Durr, Ulrich H. N. ;
Sudheendra, U. S. ;
Ramamoorthy, Ayyalusamy .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09) :1408-1425
[6]  
Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P124
[7]   Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial [J].
Gronberg, Alvar ;
Mahlapuu, Margit ;
Stahle, Mona ;
Whately-Smith, Caroline ;
Rollman, Ola .
WOUND REPAIR AND REGENERATION, 2014, 22 (05) :613-621
[8]   The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium [J].
Heilborn, JD ;
Nilsson, MF ;
Kratz, G ;
Weber, G ;
Sorensen, O ;
Borregaard, N ;
Ståhle-Bäckdahl, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (03) :379-389
[9]   Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37 [J].
Henzler-Wildman, KA ;
Martinez, GV ;
Brown, MF ;
Ramamoorthy, A .
BIOCHEMISTRY, 2004, 43 (26) :8459-8469
[10]   Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37 [J].
Johansson, J ;
Gudmundsson, GH ;
Rottenberg, ME ;
Berndt, KD ;
Agerberth, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3718-3724